Chaoju Eye Care Holdings Limited (Chaoju Eye Care) has filed its Monthly Return for Equity Issuer for the period ended 31 May 2026, confirming a steady share capital position and full compliance with Hong Kong Stock Exchange public-float requirements.

Authorised share capital • Authorized share count remained unchanged at 1.52 billion ordinary shares with a par value of HKD 0.00025 each, keeping total authorised capital steady at HKD 0.38 million.

Issued shares and treasury shares • Issued shares (excluding treasury shares): 705.18 million, unchanged from the previous month. • Treasury shares: none held. • Consequently, total issued share capital also stood unchanged at 705.18 million shares.

Public-float compliance • The company affirmed that at month-end it met the Main Board’s minimum public-float requirement of 25 percent of issued shares.

Share repurchases pending cancellation • Although no new repurchases occurred in May, 742,000 shares repurchased on 6 June 2025 (382,000 shares) and 12 May 2026 (360,000 shares) remain pending formal cancellation. These shares are excluded from the issued-share figure reported above.

No outstanding share options, warrants, convertibles or other share-issuance arrangements were recorded for the month. The return was signed by Executive Director and Joint Company Secretary Zhang Guangdi on 2 June 2026.